Daxor Corp
NASDAQ:DXR
Operating Margin
Daxor Corp
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
|
Daxor Corp
NASDAQ:DXR
|
36.8m USD |
-1 303%
|
|
| US |
|
Abbott Laboratories
NYSE:ABT
|
216.2B USD |
17%
|
|
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
165.1B USD |
28%
|
|
| US |
|
Boston Scientific Corp
NYSE:BSX
|
134.9B USD |
18%
|
|
| US |
|
Stryker Corp
NYSE:SYK
|
131.7B USD |
22%
|
|
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.7B USD |
19%
|
|
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
59.5B USD |
14%
|
|
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
48.9B EUR |
13%
|
|
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
40.6B USD |
27%
|
|
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
257.6B CNY |
36%
|
|
| US |
|
Resmed Inc
NYSE:RMD
|
31.3B USD |
32%
|
Daxor Corp
Glance View
Daxor Corp. is a biotechnology company which develops and manufactures the BVA-100 blood volume analyzer, an instrument that measures human blood volume. The company is headquartered in New York City, New York. The Company’s investment objectives are capital preservation, maintaining returns on capital with a high degree of safety and generating income from dividends and option sales to help offset operating losses from the Company’s operating division. The firm intends to maintain a diversified securities portfolio comprised primarily of electric utility company common and preferred stocks. The firm seeks to maintain a minimum of 80% of its portfolio in equity securities of utility companies.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Daxor Corp's most recent financial statements, the company has Operating Margin of -1 303.2%.
You don't have any saved screeners yet